COMMUNIQUÉS West-GlobeNewswire

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/07/2025
CHARLESTOWN, Mass., July 01, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today [...]
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/07/2025
NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara” or the “Company”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare [...]
Lixte Biotechnology Holdings, Inc. Announces $5.0 Million Private Placement Priced at the Market
01/07/2025
PASADENA, CALIF, July 01, 2025 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) (the “Company”), a clinical stage pharmaceutical company, today announced that, on June 30, 2025 intraday, it entered [...]
Serina Therapeutics Announces Date for 2025 Annual Stockholders Meeting
01/07/2025
HUNTSVILLE, July 01, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company, today announced that its Board of Directors has established November 7, [...]
Vireo Growth Inc. and Curio Wellness Announce Manufacturing and Distribution Partnership
01/07/2025
-- Leading cannabis companies partner to leverage existing IP and brand value in New York -- CHICAGO and MINNEAPOLIS, July 01, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (“Vireo” or the “Company”) (CSE: VREO; OTCQX: [...]
WeightWatchers and Novo Nordisk Expand Collaboration to Improve Medication Access Through Trusted, Holistic Model of Care
01/07/2025
WeightWatchers Clinic Members Can Access FDA-Approved Wegovy ® for $299 in July, a $200 Savings Offer to Improve Access as WeightWatchers’ Trusted, Science-Backed Approach Continues to Lead the Industry Collaboration [...]
Pennant Announces Home Health Acquisition in Southern California
01/07/2025
EAGLE, Idaho, July 01, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announces the [...]
Cidara Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
01/07/2025
SAN DIEGO, July 01, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company applying its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) therapeutics, today [...]
Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01/07/2025
SAN DIEGO, July 01, 2025 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for [...]
ProKidney Corp. Completes Domestication from the Cayman Islands to Delaware
01/07/2025
WINSTON-SALEM, N.C., July 01, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), [...]
Fred Meyer and Washington State Collaborate to Provide Free Locking Bags to Prevent Opioid Misuse
01/07/2025
Olympia, Washington, July 01, 2025 (GLOBE NEWSWIRE) -- Customers at Fred Meyer’s 60 pharmacies in Washington now have access to free locking bags to more safely store their opioid prescriptions. The Washington State [...]
Processa Pharmaceuticals Provides Portfolio and Business Update
01/07/2025
Signed binding term sheet granting Intact Therapeutics an exclusive option to license PCS12852 Continue enrolling patients in Phase 2 study of PCS6422 Strengthened balance sheet with $7M capital infusion VERO BEACH, Fla [...]
Visory Health Wins Gold at the 2025 Digital Health Awards
01/07/2025
Award-winning health tech company brings prescription savings to over 38,700 pharmacies nationwide ESTERO, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- Visory Health , a leading patient-first health tech prescription [...]
Inmagene Doses First Patient in the ADAPTIVE Phase 2b Trial of IMG-007, a Nondepleting Anti-OX40 mAb with an Extended Half-life, in Patients with Moderate-to-Severe Atopic Dermatitis
01/07/2025
The ADAPTIVE Phase 2b trial evaluates multiple dose regimens of IMG-007 in patients with moderate-to-severe atopic dermatitis Topline data expected in the fourth quarter of 2026 SAN DIEGO, July 01, 2025 (GLOBE NEWSWIRE [...]
Femasys Achieves Australian and New Zealand Regulatory Approvals for FemaSeed® for First-Line Infertility Treatment and FemVue Diagnostic
01/07/2025
-- Milestone expands global reach and reinforces commitment to accessible, first-line infertility solutions -- ATLANTA, July 01, 2025 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical innovator [...]
LiveWorld Releases First-Ever AI Brand Reputation Index for Leading OTC Brands
01/07/2025
Study highlights how AI tools like ChatGPT are shaping reputation and consumer perception of leading OTC brands CAMPBELL, Calif. and NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Campbell, California and New York City – [...]
First Clinical Results from MAGiC Catheter Study Published in the Journal of Interventional Cardiac Electrophysiology
01/07/2025
ST. LOUIS, July 01, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the publication of initial [...]
Trinity Biotech Reaches Profitability Inflection Point, Marking Major Milestone in Strategic Turnaround
01/07/2025
-Trinity Biotech projects it reached Adjusted EBITDA 1 -positive operations during Q2 2025 and expects to be Adjusted EBITDA 1 positive going forward, reflecting continued strong execution on its comprehensive [...]
Cellectar Biosciences Announces Pricing of $6 Million Underwritten Public Offering
01/07/2025
FLORHAM PARK, N.J., July 01, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB) (the “Company”), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the [...]

Pages